{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-098462","form_type":"8-K","ticker":"MOVE","cik":"0001734750","company_name":"Corvex, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.403343+00:00","generated_at":"2026-05-30T00:31:42.215950+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Movano Health reports Q3 operating loss $7.4M, ships 339 Evie Rings, reverse split completed","bullets":["Operating loss of $7.4M in Q3 2024, improved from $9.1M loss in Q3 2023.","Cash and equivalents at Sept 30, 2024: $11.3M.","1-for-15 reverse stock split executed Oct 29; Nasdaq bid price compliance regained Nov 12.","EvieMED 510(k) review in final stage; complete response submitted late Oct for medical features.","Entered agreement phase for Q1 2025 pilot program with large healthcare company using EvieMED."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-098462","json":"https://secwatch.observer/filing/0001213900-24-098462.json","markdown":"https://secwatch.observer/filing/0001213900-24-098462.md","text":"https://secwatch.observer/filing/0001213900-24-098462.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1734750/000121390024098462/0001213900-24-098462-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1734750/000121390024098462/ea0220897-8k_movano.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:31:42.215950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}